Pharmaceutical Technology
NOVEMBER 24, 2022
Understanding how a drug will act in the body, including how it is absorbed, distributed, and eventually eliminated, is a crucial component of drug research. Well-planned ADME investigations are conducted in the early stages of clinical research to generate this important data, which is needed for regulatory submissions.
Cloudbyz
MARCH 5, 2024
The complexities in clinical research in both Clinical research for both biologics and small molecules involves complex processes that are crucial for demonstrating safety, efficacy, and quality before obtaining regulatory approval. Enhancing bioavailability is often a key focus in the development of small molecule drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 13, 2023
At Quotient Sciences, our drug development consultants use our 30+ years of experience in clinical research outcomes to profile each new molecule that we look at. Quotient Sciences was asked to select the best candidate based on material science and oral bioavailability considerations.
Roots Analysis
MARCH 2, 2022
However, it is important to highlight that there are still several challenges which need to be addressed in order to develop biologic drugs capable of effectively being administered via the oral route without undergoing significant losses in specificity and / or bioavailability. Oral Protein / Peptide-based Drugs.
XTalks
SEPTEMBER 24, 2024
XTALKS CLINICAL EDGE: Issue 3 — Interview with Marinus Pharmaceuticals’ Dr. Flatt Xtalks Clinical Edge is a magazine for clinical research professionals and all who want to be informed about the latest trends and happenings in clinical trials.
The Pharma Data
MARCH 11, 2021
Session Category: Clinical Research (Excluding Trials). Session Title: Disease-Oriented Innovative Clinical Research and Trials. Session Type: Clinical Trials Minisymposium. Abstract Number: 442. Session Title: Combination Immunotherapies. Session Type: E-Poster Session. Sintilimab. Abstract Number: CT041.
XTalks
AUGUST 30, 2022
Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. Consider targeting your therapies that fail to be orally bioavailable and brain penetrant. The patients are waiting!
Expert insights. Personalized for you.
130 
Let's personalize your content